Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Identification of rare nonsynonymous variants in SYNE1/CPG2 in bipolar affective disorder.

Sharp SI, Lange J, Kandaswamy R, Daher M, Anjorin A, Bass NJ, McQuillin A.

Psychiatr Genet. 2017 Jun;27(3):81-88. doi: 10.1097/YPG.0000000000000166.

PMID:
28178086
2.

Identification of shared risk loci and pathways for bipolar disorder and schizophrenia.

Forstner AJ, Hecker J, Hofmann A, Maaser A, Reinbold CS, Mühleisen TW, Leber M, Strohmaier J, Degenhardt F, Treutlein J, Mattheisen M, Schumacher J, Streit F, Meier S, Herms S, Hoffmann P, Lacour A, Witt SH, Reif A, Müller-Myhsok B, Lucae S, Maier W, Schwarz M, Vedder H, Kammerer-Ciernioch J, Pfennig A, Bauer M, Hautzinger M, Moebus S, Schenk LM, Fischer SB, Sivalingam S, Czerski PM, Hauser J, Lissowska J, Szeszenia-Dabrowska N, Brennan P, McKay JD, Wright A, Mitchell PB, Fullerton JM, Schofield PR, Montgomery GW, Medland SE, Gordon SD, Martin NG, Krasnov V, Chuchalin A, Babadjanova G, Pantelejeva G, Abramova LI, Tiganov AS, Polonikov A, Khusnutdinova E, Alda M, Cruceanu C, Rouleau GA, Turecki G, Laprise C, Rivas F, Mayoral F, Kogevinas M, Grigoroiu-Serbanescu M, Becker T, Schulze TG, Rietschel M, Cichon S, Fier H, Nöthen MM.

PLoS One. 2017 Feb 6;12(2):e0171595. doi: 10.1371/journal.pone.0171595. eCollection 2017.

3.

Genetic variation in the miR-708 gene and its binding targets in bipolar disorder.

Fiorentino A, O'Brien NL, Sharp SI, Curtis D, Bass NJ, McQuillin A.

Bipolar Disord. 2016 Dec;18(8):650-656. doi: 10.1111/bdi.12448. Epub 2016 Nov 16.

4.

The NCAN gene: schizophrenia susceptibility and cognitive dysfunction.

Wang P, Cai J, Ni J, Zhang J, Tang W, Zhang C.

Neuropsychiatr Dis Treat. 2016 Nov 4;12:2875-2883. eCollection 2016.

5.

Leveraging electronic health records to study pleiotropic effects on bipolar disorder and medical comorbidities.

Prieto ML, Ryu E, Jenkins GD, Batzler A, Nassan MM, Cuellar-Barboza AB, Pathak J, McElroy SL, Frye MA, Biernacka JM.

Transl Psychiatry. 2016 Aug 16;6:e870. doi: 10.1038/tp.2016.138.

6.

Investigating the Impact of a Genome-Wide Supported Bipolar Risk Variant of MAD1L1 on the Human Reward System.

Trost S, Diekhof EK, Mohr H, Vieker H, Krämer B, Wolf C, Keil M, Dechent P, Binder EB, Gruber O.

Neuropsychopharmacology. 2016 Oct;41(11):2679-87. doi: 10.1038/npp.2016.70. Epub 2016 May 13.

PMID:
27184339
7.

Obsessive-compulsive symptoms in a large population-based twin-family sample are predicted by clinically based polygenic scores and by genome-wide SNPs.

den Braber A, Zilhão NR, Fedko IO, Hottenga JJ, Pool R, Smit DJ, Cath DC, Boomsma DI.

Transl Psychiatry. 2016 Feb 9;6:e731. doi: 10.1038/tp.2015.223.

8.

In Sickness and in Health: Perineuronal Nets and Synaptic Plasticity in Psychiatric Disorders.

Pantazopoulos H, Berretta S.

Neural Plast. 2016;2016:9847696. doi: 10.1155/2016/9847696. Epub 2015 Dec 29. Review.

9.

DNA methylation in a Scottish family multiply affected by bipolar disorder and major depressive disorder.

Walker RM, Christoforou AN, McCartney DL, Morris SW, Kennedy NA, Morten P, Anderson SM, Torrance HS, Macdonald A, Sussmann JE, Whalley HC, Blackwood DH, McIntosh AM, Porteous DJ, Evans KL.

Clin Epigenetics. 2016 Jan 20;8:5. doi: 10.1186/s13148-016-0171-z. eCollection 2016.

10.

A significant risk locus on 19q13 for bipolar disorder identified using a combined genome-wide linkage and copy number variation analysis.

Lekman M, Karlsson R, Graae L, Hössjer O, Kockum I.

BioData Min. 2015 Dec 18;8:42. doi: 10.1186/s13040-015-0076-y. eCollection 2015.

11.

A genome-wide association study of bipolar disorder with comorbid eating disorder replicates the SOX2-OT region.

Liu X; Bipolar Genome Study (BiGS), Kelsoe JR, Greenwood TA.

J Affect Disord. 2016 Jan 1;189:141-9. doi: 10.1016/j.jad.2015.09.029. Epub 2015 Sep 25.

12.

Impact of a cis-associated gene expression SNP on chromosome 20q11.22 on bipolar disorder susceptibility, hippocampal structure and cognitive performance.

Li M, Luo XJ, Landén M, Bergen SE, Hultman CM, Li X, Zhang W, Yao YG, Zhang C, Liu J, Mattheisen M, Cichon S, Mühleisen TW, Degenhardt FA, Nöthen MM, Schulze TG, Grigoroiu-Serbanescu M, Li H, Fuller CK, Chen C, Dong Q, Chen C, Jamain S, Leboyer M, Bellivier F, Etain B, Kahn JP, Henry C, Preisig M, Kutalik Z, Castelao E, Wright A, Mitchell PB, Fullerton JM, Schofield PR, Montgomery GW, Medland SE, Gordon SD, Martin NG; MooDS Consortium; Swedish Bipolar Study Group, Rietschel M, Liu C, Kleinman JE, Hyde TM, Weinberger DR, Su B.

Br J Psychiatry. 2016 Feb;208(2):128-37. doi: 10.1192/bjp.bp.114.156976. Epub 2015 Sep 3.

13.

Assessment of first and second degree relatives of individuals with bipolar disorder shows increased genetic risk scores in both affected relatives and young At-Risk Individuals.

Fullerton JM, Koller DL, Edenberg HJ, Foroud T, Liu H, Glowinski AL, McInnis MG, Wilcox HC, Frankland A, Roberts G, Schofield PR, Mitchell PB, Nurnberger JI; Bipolar High Risk Study Group, BiGS Consortium.

Am J Med Genet B Neuropsychiatr Genet. 2015 Oct;168(7):617-29. doi: 10.1002/ajmg.b.32344. Epub 2015 Jul 16.

14.

Epistatic and gene wide effects in YWHA and aromatic amino hydroxylase genes across ADHD and other common neuropsychiatric disorders: Association with YWHAE.

Jacobsen KK, Kleppe R, Johansson S, Zayats T, Haavik J.

Am J Med Genet B Neuropsychiatr Genet. 2015 Sep;168(6):423-432. doi: 10.1002/ajmg.b.32339. Epub 2015 Jul 14.

15.

Development of a bipolar disorder biobank: differential phenotyping for subsequent biomarker analyses.

Frye MA, McElroy SL, Fuentes M, Sutor B, Schak KM, Galardy CW, Palmer BA, Prieto ML, Kung S, Sola CL, Ryu E, Veldic M, Geske J, Cuellar-Barboza A, Seymour LR, Mori N, Crowe S, Rummans TA, Biernacka JM.

Int J Bipolar Disord. 2015 Dec;3(1):30. doi: 10.1186/s40345-015-0030-4. Epub 2015 Jun 24.

16.

Genome-wide association study of behavioural and psychiatric features in human prion disease.

Thompson AG, Uphill J, Lowe J, Porter MC, Lukic A, Carswell C, Rudge P, MacKay A, Collinge J, Mead S.

Transl Psychiatry. 2015 Apr 21;5:e552. doi: 10.1038/tp.2015.42.

17.

NCAN Cross-Disorder Risk Variant Is Associated With Limbic Gray Matter Deficits in Healthy Subjects and Major Depression.

Dannlowski U, Kugel H, Grotegerd D, Redlich R, Suchy J, Opel N, Suslow T, Konrad C, Ohrmann P, Bauer J, Kircher T, Krug A, Jansen A, Baune BT, Heindel W, Domschke K, Forstner AJ, Nöthen MM, Treutlein J, Arolt V, Hohoff C, Rietschel M, Witt SH.

Neuropsychopharmacology. 2015 Oct;40(11):2510-6. doi: 10.1038/npp.2015.86. Epub 2015 Mar 24.

18.

Losing the sugar coating: potential impact of perineuronal net abnormalities on interneurons in schizophrenia.

Berretta S, Pantazopoulos H, Markota M, Brown C, Batzianouli ET.

Schizophr Res. 2015 Sep;167(1-3):18-27. doi: 10.1016/j.schres.2014.12.040. Epub 2015 Jan 16. Review.

19.

Quantitative leukocyte BDNF promoter methylation analysis in bipolar disorder.

Strauss JS, Khare T, De Luca V, Jeremian R, Kennedy JL, Vincent JB, Petronis A.

Int J Bipolar Disord. 2013 Dec 30;1:28. doi: 10.1186/2194-7511-1-28. eCollection 2013.

20.

Extracellular matrix control of dendritic spine and synapse structure and plasticity in adulthood.

Levy AD, Omar MH, Koleske AJ.

Front Neuroanat. 2014 Oct 20;8:116. doi: 10.3389/fnana.2014.00116. eCollection 2014. Review.

Supplemental Content

Support Center